Literature DB >> 30044260

Lymphocytic Thrombophilic Arteritis: A Review.

Sharif Vakili1, John G Zampella2, Shawn G Kwatra1, Jaime Blanck3, Manisha Loss1.   

Abstract

Macular lymphocytic arteritis or lymphocytic thrombophilic arteritis (LTA) is a recently described cutaneous arteritis that is characterized by asymptomatic macules and patches of the extremities associated with lymphocytic arteritis at the deep dermal/subcuticular junction for which little information exists on demographics, evaluation, and management. There has been recent debate in the literature whether this disease is a new distinct entity, misdiagnosed cutaneous polyarteritis nodosa (cPAN), or a disease on a spectrum with cPAN. We systematically review the literature on demographic information, medical history, histopathology findings, and treatment management to analyze trends and clarify controversies in characterizations of LTA. Forty detailed cases of LTA have been published. We submit that, although literature is limited, a review of the data still suggests that LTA is distinct from cPAN and systemic PAN. In addition, to better reflect the pathophysiologic natural history of this condition and correct for the historical artifact of how the disease was identified, we encourage the disease to be referred to as LTA and discourage ongoing use of macular lymphocytic arteritis.

Entities:  

Mesh:

Year:  2019        PMID: 30044260     DOI: 10.1097/RHU.0000000000000846

Source DB:  PubMed          Journal:  J Clin Rheumatol        ISSN: 1076-1608            Impact factor:   3.517


  2 in total

1.  Macular arteritis in an HIV-infected patient improving with adherence to antiretroviral therapy.

Authors:  Elisabeth Boddé; Jeffrey Damman; Martijn B A van Doorn
Journal:  JAAD Case Rep       Date:  2020-06-14

2.  Serologic Abnormalities in Macular Lymphocytic Arteritis with Case Presentation.

Authors:  Nicole R Bender; Elizabeth L Bisbee; Douglas Robins; Kiran Motaparthi; Vladimir Vincek
Journal:  Case Rep Dermatol       Date:  2022-01-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.